AZD-8055 Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00731263A Study of Tor Kinase Inhibitor in Advanced Tumors